Development of an acute lung injury model for drug testing
Abstract A challenge that limits our understanding of the underlying pathobiology of pediatric acute respiratory distress syndrome (PARDS) is the lack of a preclinical airway model that can be leveraged for the study of mechanisms and specific molecules for drug testing. We developed a physiologic m...
Saved in:
| Main Authors: | Jocelyn R. Grunwell, Susan T. Stephenson, Gail A. Dallalio, Badiallo A. Diani, Celena Zaworski, Natalie Jordan, Anne M. Fitzpatrick |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02078-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
by: Andreas Wollenberg, et al.
Published: (2024-12-01) -
Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways
by: Armando S. Flores-Torres, et al.
Published: (2025-05-01) -
An uncommon diagnosis behind a common respiratory symptom: Lobular capillary hemangioma of the trachea in a pediatric patient
by: Alireza Eshghi, et al.
Published: (2025-10-01) -
JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01) -
The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids
by: Corinna Boden, et al.
Published: (2025-04-01)